Evidence map›Paper›PMID 37747872›Full record

ArticlePLOS global public health2023

What went right during the COVID crisis: The capabilities of local actors and lasting innovations in oncology care and research.

Brenda Bogaert, Zisis Kozlakidis, Elodie Caboux, Julien Péron, Pierre Saintingy

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLOS global public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Brenda BogaertDepartment of Social Sciences and Humanities, Centre Léon Bérard, Lyon, France and Institut des Humanités en Médecine, UNIL/CHUV, Lausanne, Switzerland.ORCID https://orcid.org/0000-0001-7557-3709
Zisis KozlakidisInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Elodie CabouxInternational Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID https://orcid.org/0000-0001-8393-6979
Julien PéronDepartment of Medical Oncology and Research Center on Healthcare Performance (RESHAPE) INSERM U1290, Hospices Civils de Lyon, Pierre-Benite, France.
Pierre SaintingyDepartment of Medical Oncology, Centre Léon Bérard and Claude Bernard Lyon 1 University, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.ORCID https://orcid.org/0000-0002-8090-9323
Centre international de recherche sur le cancer · FRInserm · FRUniversité Claude Bernard Lyon 1 · FRUniversity Hospital of Lausanne · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

This article will elaborate how oncology care and research was adapted during the COVID pandemic in the Metropole of Lyon (France), including the lasting innovations that came out of the crisis. The research method involved 22 semi-structured qualitative interviews of healthcare professionals, managers, and researchers in the Lyon, France region coming from both public and private academic hospitals. The interviews took place from February 2021-December 2022 in order to assess the long-term adaptations and innovations in cancer care organization in the post-COVID era. The main results show adaptations and innovations in 1) new processes and resources to facilitate disciplinary and interdisciplinary work; 2) harmonization and streamlining of patient journeys. In the discussion section, we will mobilize the capabilities approach, an interdisciplinary social sciences approach that focuses on the capabilities of persons to be and to do, to elaborate the conditions by which local actors were able to be agile, to adapt and to innovate in spite of the healthcare emergency and in coherence with their professional and personal values.

Identifiers

PMID37747872
PMCPMC10519589
OpenAlexW4387013923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.